Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Assetmark Inc.

Assetmark Inc. cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 82.9% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 24,489 shares of the company’s stock after selling 119,055 shares during the period. Assetmark Inc.’s holdings in Option Care Health were worth $767,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. raised its position in shares of Option Care Health by 317.9% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after acquiring an additional 73,312 shares in the last quarter. Comerica Bank grew its stake in Option Care Health by 6.5% during the 1st quarter. Comerica Bank now owns 760,915 shares of the company’s stock worth $25,521,000 after buying an additional 46,639 shares during the last quarter. Janus Henderson Group PLC grew its stake in Option Care Health by 182.9% during the 1st quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock worth $7,617,000 after buying an additional 146,837 shares during the last quarter. Edgestream Partners L.P. grew its stake in Option Care Health by 96.8% during the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after buying an additional 172,845 shares during the last quarter. Finally, XTX Topco Ltd bought a new position in Option Care Health during the 2nd quarter worth $973,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Option Care Health

In related news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The trade was a 8.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on OPCH shares. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. JMP Securities raised their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Barrington Research decreased their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Finally, Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and decreased their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $30.83.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $21.93 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market cap of $3.73 billion, a price-to-earnings ratio of 18.43, a P/E/G ratio of 2.30 and a beta of 1.32. The business’s 50-day simple moving average is $28.82 and its 200-day simple moving average is $29.44. Option Care Health, Inc. has a 52 week low of $21.64 and a 52 week high of $34.63.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.